Latest News - Valeant NJ

Tuesday, July 18, 2017 | Acquisitions and Mergers, Personnel/Company News,, Obagi, Valeant NJ

Valeant to Sell Obagi Medical Products Unit for $190 Million

In a deal valued at $190 million in cash, Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its Obagi Medical Products business to Haitong International Zhong…

Read the full story

Thursday, February 23, 2017 | Personnel/Company News, Product Launches and Updates, Obagi, Valeant NJ

Obagi Teams Up with Suzan Obagi, MD and Nextcell Medical to Introduce New Skincare Line

Obagi Medical Products, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., has collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD&rsqu…

Read the full story

Tuesday, January 10, 2017 | Personnel/Company News,, Valeant NJ

Valeant Offloads CeraVe, AcneFree And AMBI To L'Oréal

Valeant Pharmaceuticals International, Inc. is selling CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. The transaction is expected to close in th…

Read the full story

Tuesday, December 13, 2016 | Personnel/Company News, Valeant NJ

Valeant Appoints New EVP, Dermatology

Valeant Pharmaceuticals International, Inc. appointed William D. Humphries as Executive Vice President, Dermatology, effective January 2, 2017.  Mr. Humphries will join Valeant's Executive Co…

Read the full story

Thursday, November 17, 2016 |, Product Launches and Updates, Valeant NJ

Cerave To Debut New Day Cream, Gel Oil

Cerave is expanding their Renewing product line. A new Cerave Skin Renewing Day Cream with Broad Spectrum SPF 30 sunscreen and Skin Renewing Gel Oil now join existing products in this line includin…

Read the full story